136 related articles for article (PubMed ID: 9245959)
1. MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings.
Kane PA; Ayton V; Walters HL; Benjamin I; Heaton ND; Williams R; Karani JB
Acta Radiol; 1997 Jul; 38(4 Pt 2):650-4. PubMed ID: 9245959
[TBL] [Abstract][Full Text] [Related]
2. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
3. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
Rummeny EJ; Torres CG; Kurdziel JC; Nilsen G; Op de Beeck B; Lundby B
Acta Radiol; 1997 Jul; 38(4 Pt 2):638-42. PubMed ID: 9245957
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Wang C; Ahlström H; Ekholm S; Fagertun H; Hellström M; Hemmingsson A; Holtås S; Isberg B; Jonnson E; Lönnemark-Magnusson M; McGill S; Wallengren NO; Westman L
Acta Radiol; 1997 Jul; 38(4 Pt 2):643-9. PubMed ID: 9245958
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
6. MnDPDP for MR imaging of the liver. Results from the European phase III studies.
Torres CG; Lundby B; Sterud AT; McGill S; Gordon PB; Bjerknes HS
Acta Radiol; 1997 Jul; 38(4 Pt 2):631-7. PubMed ID: 9245956
[TBL] [Abstract][Full Text] [Related]
7. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
[TBL] [Abstract][Full Text] [Related]
8. MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion.
Thorstensen O; Isberg B; Jorulf H; Westman L; Svahn U; Venizelos N
Acta Radiol; 1997 Jul; 38(4 Pt 2):717-23. PubMed ID: 9245967
[TBL] [Abstract][Full Text] [Related]
9. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Helmberger TK; Laubenberger J; Rummeny E; Jung G; Sievers K; Döhring W; Meurer K; Reiser MF
Eur Radiol; 2002 Jan; 12(1):62-70. PubMed ID: 11868075
[TBL] [Abstract][Full Text] [Related]
10. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
Ni Y; Petré C; Bosmans H; Miao Y; Grant D; Baert AL; Marchal G
Acta Radiol; 1997 Jul; 38(4 Pt 2):700-7. PubMed ID: 9245965
[TBL] [Abstract][Full Text] [Related]
11. NMR relaxation studies with MnDPDP.
Southon TE; Grant D; Bjørnerud A; Moen OM; Spilling B; Martinsen I; Refsum H
Acta Radiol; 1997 Jul; 38(4 Pt 2):708-16. PubMed ID: 9245966
[TBL] [Abstract][Full Text] [Related]
12. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Ni Y; Marchal G
Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968
[TBL] [Abstract][Full Text] [Related]
15. MnDPDP as a negative hepatic contrast agent: evaluation of STIR imaging compared with T1-weighted SE and GE techniques.
Halavaara JT; Lamminen AE
J Comput Assist Tomogr; 1997; 21(1):94-9. PubMed ID: 9022776
[TBL] [Abstract][Full Text] [Related]
16. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
Wang C; Gordon PB; Hustvedt SO; Grant D; Sterud AT; Martinsen I; Ahlström H; Hemmingsson A
Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962
[TBL] [Abstract][Full Text] [Related]
17. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
[TBL] [Abstract][Full Text] [Related]
18. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Burkill GJ; Mannion EM; Healy JC
Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
[TBL] [Abstract][Full Text] [Related]
19. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Bartolozzi C; Donati F; Cioni D; Crocetti L; Lencioni R
Eur Radiol; 2000; 10(11):1697-702. PubMed ID: 11097390
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]